UMass Memorial Secures Approval for $54 Million Cancer Facility

UMass Memorial Health has received approval from the state Public Health Council to construct a new cancer care facility in Marlborough, Massachusetts. The project, estimated to cost $54 million, will introduce proton therapy as an alternative to traditional radiation treatment. This significant development aims to enhance access to advanced cancer care for patients in the region.

Proton therapy utilizes a beam of charged protons to target tumors more precisely than conventional radiation, which often involves X-rays that can inadvertently affect surrounding healthy tissues. Currently, the only proton therapy units in New England are located at the Massachusetts General Hospital in Boston, which serve approximately 640 patients annually. Many patients in Massachusetts currently travel to New York or other distant locations for this treatment due to limited availability.

Shelly Hazlett, a spokesperson for UMass Memorial, emphasized the facility’s role in addressing rising cancer cases in Central Massachusetts. “As the incidence of cancer cases rises in Central Massachusetts and throughout the state, we’re committed to remaining a leader in clinical innovation,” Hazlett stated. She further noted that the new center is essential for improving the health and quality of life for patients relying on UMass Memorial for their care.

The expansion of proton therapy access is timely, as another significant project is underway. The Dana-Farber Cancer Institute plans to develop a proton therapy center in the Longwood neighborhood of Boston, with a budget of $50 million. This project is still under review, but Dr. Allison O’Neill, Vice President for Clinical Performance Management at Dana-Farber, indicated that there is a pressing need for such facilities. “There’s currently an unmet need,” she explained.

Proponents of proton therapy highlight its advantages, particularly for pediatric patients, as it minimizes damage to healthy tissues surrounding tumors. However, the therapy has faced skepticism concerning its cost-effectiveness. Ongoing research aims to clarify the benefits of proton therapy compared to its high expenses. UMass Memorial leaders have pointed out that advancements in technology are driving costs down, potentially making proton therapy both more affordable and beneficial in the long run. They assert that this treatment can lead to reduced follow-up care and improved patients’ overall quality of life.

As UMass Memorial moves forward with this project, it aims not only to enhance cancer treatment options in the region but also to solidify its position as a leader in innovative healthcare solutions. The new facility is expected to significantly reduce the travel burden for patients seeking proton therapy, ultimately improving access to vital cancer care services.